Profil
Ori Kalid was the founder of Pi Therapeutics Ltd., founded in 2015, and held the title of Chief Executive Officer.
Dr. Kalid is currently Vice President-Research & Development at Protalix Biotherapeutics, Inc. since 2024.
Formerly, Dr. Kalid was Chief Executive Officer at Pi Therapeutics Ltd. Dr. Kalid completed undergraduate, graduate, and doctorate degrees at Tel-Aviv University.
Aktiva positioner av Ori Kalid
| Företag | Position | Start |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-06-01 |
Tidigare kända positioner av Ori Kalid
| Företag | Position | Slut |
|---|---|---|
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Verkställande Direktör | - |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Verkställande Direktör | - |
Ori Kalids utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Health Technology |
















